68 related articles for article (PubMed ID: 28614640)
1. [[Gender Differences in Tissue Cascade of Activation of Plasminogen and PAI-1 in Esophageal Squamous Cell Carcinoma].].
Kit OL; Frantsiyants EM; Kozlova LS; Kolesnikov EN; Pogorelova YA; Cheryarina ND; Tavaryan IS
Eksp Klin Gastroenterol; 2016; (5):16-21. PubMed ID: 28614640
[TBL] [Abstract][Full Text] [Related]
2. [A plasminogen regulation system in brain tumors].
Kit OI; Frantsiyants EM; Kozlova LS; Rostorguev EE; Balyazin-Parfenov IV; Pogorelova YA
Zh Vopr Neirokhir Im N N Burdenko; 2017; 81(2):22-27. PubMed ID: 28524122
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activators in oesophageal carcinoma.
Hewin DF; Savage PB; Alderson D; Vipond MN
Br J Surg; 1996 Aug; 83(8):1152-5. PubMed ID: 8869332
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator system in oral squamous cell carcinoma.
Baker EA; Leaper DJ; Hayter JP; Dickenson AJ
Br J Oral Maxillofac Surg; 2007 Dec; 45(8):623-7. PubMed ID: 17590247
[TBL] [Abstract][Full Text] [Related]
5. Clinical value of components of the plasminogen activation system in ovarian cyst fluid.
Boss EA; Massuger LF; Thomas CM; Geurts-Moespot A; van Schaik JH; Boonstra H; Sweep CG
Anticancer Res; 2002; 22(1A):275-82. PubMed ID: 12017303
[TBL] [Abstract][Full Text] [Related]
6. Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaboration.
Grebenchtchikov N; Maguire TM; Riisbro R; Geurts-Moespot A; O'Donovan N; Schmitt M; McGreal G; McDermott E; O'Higgins N; Brünner N; Sweep CG; Duffy MJ
Oncol Rep; 2005 Jul; 14(1):235-9. PubMed ID: 15944795
[TBL] [Abstract][Full Text] [Related]
7. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression.
Lockwood CJ; Krikun G; Papp C; Aigner S; Schatz F
J Clin Endocrinol Metab; 1995 Apr; 80(4):1100-5. PubMed ID: 7714076
[TBL] [Abstract][Full Text] [Related]
8. Components of the plasminogen activator system and their complexes in renal cell and bladder cancer: comparison between normal and matched cancerous tissues.
Span PN; Witjes JA; Grebenchtchikov N; Geurts-Moespot A; Moonen PM; Aalders TW; Vriesema JL; Kiemeney LA; Schalken JA; Sweep FC
BJU Int; 2008 Jul; 102(2):177-82. PubMed ID: 18336603
[TBL] [Abstract][Full Text] [Related]
9. Serine proteinase activation in esophageal cancer.
Tang WH; Friess H; Kekis PB; Martignoni ME; Fukuda A; Roggo A; Zimmerman A; Büchler MW
Anticancer Res; 2001; 21(4A):2249-58. PubMed ID: 11724279
[TBL] [Abstract][Full Text] [Related]
10. The effect of IL-1alpha on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in osteoblastic ROS 17/2.8 cells.
Fujisaki K; Tanabe N; Suzuki N; Mitsui N; Oka H; Ito K; Maeno M
Life Sci; 2006 Mar; 78(17):1975-82. PubMed ID: 16313928
[TBL] [Abstract][Full Text] [Related]
11. Progestin inhibits and thrombin stimulates the plasminogen activator/inhibitor system in term decidual stromal cells: implications for parturition.
Norwitz ER; Snegovskikh V; Schatz F; Foyouzi N; Rahman M; Buchwalder L; Lee HJ; Funai EF; Buhimschi CS; Buhimschi IA; Lockwood CJ
Am J Obstet Gynecol; 2007 Apr; 196(4):382.e1-8. PubMed ID: 17403427
[TBL] [Abstract][Full Text] [Related]
12. [Expression and significance of the urokinase-type plasminogen activator and its inhibitors in squamous cell carcinoma of human larynx].
Zhao EM; Han DM; Yu ZK; Fan EZ; Li Y
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2003 Feb; 38(1):39-42. PubMed ID: 12778766
[TBL] [Abstract][Full Text] [Related]
13. Hydrocortisone regulates the dynamics of plasminogen activator and plasminogen activator inhibitor expression in cultured murine keratinocytes.
Bator JM; Cohen RL; Chambers DA
Exp Cell Res; 1998 Jul; 242(1):110-9. PubMed ID: 9665808
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen Activation System in Rectal Adenocarcinoma.
Razik E; Kobierzycki C; Grzegrzolka J; Podhorska-Okolow M; Drag-Zalesinska M; Zabel M; Dziegiel P
Anticancer Res; 2015 Nov; 35(11):6009-15. PubMed ID: 26504024
[TBL] [Abstract][Full Text] [Related]
15. Detection of plasminogen activators in oral cancer by laser capture microdissection combined with zymography.
Curino A; Patel V; Nielsen BS; Iskander AJ; Ensley JF; Yoo GH; Holsinger FC; Myers JN; El-Nagaar A; Kellman RM; Shillitoe EJ; Molinolo AA; Gutkind JS; Bugge TH
Oral Oncol; 2004 Nov; 40(10):1026-32. PubMed ID: 15509494
[TBL] [Abstract][Full Text] [Related]
16. Expression and prognostic significance of urokinase and plasminogen activator inhibitor type-1 in endometrial hyperplasia and cancer.
Taponeco F; Curcio C; Giuntini A; Nardini V; Fornaciari G; Artini PG; D'Ambrogio G; Genazzani AR
J Exp Clin Cancer Res; 2001 Jun; 20(2):239-46. PubMed ID: 11484981
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activators and their inhibitors in human saliva and salivary gland tissue.
Virtanen OJ; Sirén V; Multanen J; Färkkilä M; Leivo I; Vaheri A; Koskiniemi M
Eur J Oral Sci; 2006 Feb; 114(1):22-6. PubMed ID: 16460337
[TBL] [Abstract][Full Text] [Related]
18. Expression of urokinase-type plasminogen activator and its receptor during ovarian follicular development.
Li M; Karakji EG; Xing R; Fryer JN; Carnegie JA; Rabbani SA; Tsang BK
Endocrinology; 1997 Jul; 138(7):2790-9. PubMed ID: 9202219
[TBL] [Abstract][Full Text] [Related]
19. Significance of plasminogen-activation system in the formation of macroscopic types and invasion in esophageal carcinoma.
Nomiya T; Nemoto K; Miyachi H; Fujimoto K; Takahashi C; Takeda K; Matushita H; Ogawa Y; Takai Y; Yamada S
Anticancer Res; 2002; 22(5):2913-6. PubMed ID: 12530017
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator activity during decidualization of human endometrial stromal cells is regulated by plasminogen activator inhibitor 1.
Schatz F; Aigner S; Papp C; Toth-Pal E; Hausknecht V; Lockwood CJ
J Clin Endocrinol Metab; 1995 Aug; 80(8):2504-10. PubMed ID: 7629251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
